Author(s): Soumaya El Baraka, Siham Yanisse, Ali Cherif Chefchaouni, Aicha Fahry, Abdelkader Laatiris, Naoual Cherkaoui, Yasser El Alaoui, Younes Rahali

Email(s): soumayaelbaraka23@gmail.com

DOI: 10.52711/0974-360X.2024.00413   

Address: Soumaya El Baraka1, Siham Yanisse2, Ali Cherif Chefchaouni1, Aicha Fahry1, Abdelkader Laatiris1, Naoual Cherkaoui1, Yasser El Alaoui1, Younes Rahali1
1Team of Formulation and Quality Control of Health Products, Laboratory of Pharmaceutics, Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Rabat, Morocco.
2Galenic Laboratory of Faculty of Medicine and Pharmacy of Marrakesh, Cadi Ayyad University of Marrakesh.
*Corresponding Author

Published In:   Volume - 17,      Issue - 6,     Year - 2024


ABSTRACT:
Objective: Class II and IV drug on the Biopharmaceutical Classification System are those with the commonest solubility issues. The objective of this work is to study the effect of the use of cyclodextrin combined with each PVP, and PEG 6000 individually, then combined, and the enhancement of solubility and dissolution rate on three BCS class II celecoxib and Valsartan, and Class IV Furosemide. Methods: A serie of 23factorial experiments were conducted. Drug´s solubilities were assessed in eight selected fluids containing Beta Cyclodextrin, Polyvinylpyrrolidone and Poly Ethylene Glycol 6000 individually and in binary and ternary combinations. Solid inclusion complexes of each drug beta Cyclodextrin, Polyvinylpyrrolidone and Poly Ethylene Glycol 6000 were prepared by kneading method, to evaluation the impact of each excipient on dissolution rates per 23factorial design. Results: Solubility levels of the three studied drugs was highly enhanced by the studied excipients. The highest solubility improvement was recorded for the combination of ßCD with PEG 6000 (4,95ratio) IN THE CASE OF Celecoxib, and forß-CD in combination with PEG 6000 and PVP (25,52 ratio) in the case of FSD, then in the combination of ßCD with PEG 6000 (21, 41ratio) in the case of Valsartan. The highest enhancement of celecoxib dissolution rates was recorded for CCX-ßCD (1:2) - PEG 6000 (2%) combination (10,03 ratio), for FSD- ßCD (1:2)-PEG 6000 (2%)-PVP (2%) combination (22,61 ratio) in the case of furosemide and for VST-PVP (2%) combination (3,54ratio) in the case of Valsartan. Conclusion: PEG 6000 is a suitable solubilizer alone and in combination with ßCD and PVP to enhance the solubility and dissolution rate of the selected three BCS Class II and IV drugs.


Cite this article:
Soumaya El Baraka, Siham Yanisse, Ali Cherif Chefchaouni, Aicha Fahry, Abdelkader Laatiris, Naoual Cherkaoui, Yasser El Alaoui, Younes Rahali. BCS Class II and IV Drug´s Solubilisation using Cycodextrin-PVP-PEG6000 Complexes through a Factorial Study Design. Research Journal of Pharmacy and Technology. 2024; 17(6):2639-3. doi: 10.52711/0974-360X.2024.00413

Cite(Electronic):
Soumaya El Baraka, Siham Yanisse, Ali Cherif Chefchaouni, Aicha Fahry, Abdelkader Laatiris, Naoual Cherkaoui, Yasser El Alaoui, Younes Rahali. BCS Class II and IV Drug´s Solubilisation using Cycodextrin-PVP-PEG6000 Complexes through a Factorial Study Design. Research Journal of Pharmacy and Technology. 2024; 17(6):2639-3. doi: 10.52711/0974-360X.2024.00413   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-6-32


REFERENCES:
1.    Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004; 56(9): 1273–1289. doi.org/10.1016/j.addr.2003.12.004.
2.    Karajgi S, Hajeri S, Potadar S. Utilization of Hydrotropic Solubilisation Technique for Quantitative Studies of Dexamethasone in Pharmaceutical preparations. Res. J. Pharm. Technol. 2022; 15(12): 5785–5788. doi.org/ 10.52711/0974-360X.2022.00976
3.    Irvine J, Afrose A, Islam N. Formulation and delivery strategies of ibuprofen: challenges and opportunities. Drug Dev Ind Pharm. 2018; 44(2): 173–183. doi.org/10.1080/03639045.2017.1391838
4.    Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007; 12(23–24): 1068–1075. doi.org/10.1016/j.drudis.2007.09.005
5.    Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev. Elsevier; 2007; 59(7): 603–616. doi.org/10.1016/j.addr.2007.05.010
6.    Jouyban-Gharamaleki A, Valaee L, Barzegar-Jalali M, Clark BJ, Acree Jr WE. Comparison of various cosolvency models for calculating solute solubility in water–cosolvent mixtures. Int J Pharm. 1999; 177(1): 93–101. doi.org/10.1016/s0378-5173(98)00333-0
7.    Shaikh FI, Patel MB, Surti NI, Patel VB. Preparation and Characterization of Lercanidipine Hydrochloride Inclusion complex with β-cyclodextrin and effect of Complexation on Solubility and Dissolution. Res J Pharm Technol. 2017; 10(4): 1041–1048. doi.org/10.5958/0974-360X.2017.00189.5
8.    Vyas A, Gidwani B, Tripathi A, Dhruve P. Significance of jobs plot in cyclodextrin complexation. Res J Pharm Technol. 2016; 9(7): 1013–1016. doi.org/10.5958/0974-360X.2016.00191.8
9.    Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs. J Pharm Sci. 1999; 88(11): 1107–1111. doi.org/10.1021/js990159d
10.    Monti S, Sortino S. Photoprocesses of photosensitizing drugs within cyclodextrin cavities. Chem Soc Rev. 2002; 31(5): 287–300. doi.org/10.1039/B106751F
11.    Kumar AY, Setty CM. Preparation and Evaluation of Nateglinide-Cyclodextrin Inclusion Complex. Res J Pharm Technol. 2018; 11(3): 1017–1022. doi.org/10.5958/0974-360X.2018.00190.7
12.    Rathi S, Patel D, Shah S. Physicochemical characterization and in-vitro dissolution behavior of artemether and lumefantrine: hydroxypropyl-β-cyclodextrin inclusion complex. Res J Pharm Technol. 2020; 13(3): 1137–1141. doi.org/10.5958/0974-360X.2020.00209.7
13.    Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macrocycl Chem. 2006; 56: 209–213. doi.org/ 10.1007/s10847-006-9085-2
14.    Bezerra FM, Carmona ÓG, Carmona CG, Plath AMS, Lis M. Biofunctional wool using β-cyclodextrins as vehiculizer of citronella oil. Process Biochem. 2019; 77: 151–158. doi.org/10.1016/j.procbio.2018.11.018
15.    Kurakula M, Rao GK. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Deliv Sci Technol. 2020; 60. doi.org/10.1016/j.jddst.2020.102046
16.    Luo Y, Hong Y, Shen L, Wu F, Lin X. Multifunctional role of polyvinylpyrrolidone in pharmaceutical formulations. AAPS Pharm Sci Tech. 2021; 22: 1–16. doi.org/10.1208/s12249-020-01909-4
17.    Alrouhayyah R, Sheshko TF, Suslina SN. Improving the Dissolution rate of Mefenamic acid by preparing Solid Dispersions with Polyethylene glycol 4000. Research Journal of Pharmacy and Technology. 2023; 16(7): 3115–3119. doi.org/10.52711/0974-360X.2023.00512
18.    Ulla MR, Gangadharappa HV, Vrathod N. Solubility and Dissolution Improvement of Rofecoxib Using Solid Dispesion Technique. Pak J Pharm Sci. 2008; 21(4). PMID: 18930854.
19.    Sharma A, Rastogi V, Kumar P, Prasad N. Formulation approaches for solubility enhancement by using polar or non-polar lipid components of bcs class ii drugs through lbdds. Res. J. Pharm. Technol. 2020; 13(8): 3918–3928. doi.org/10.5958/0974-360X.2020.00694.0
20.    Thomas JE, Nayak UY, Jagadish PC, Koteshwara KB. Design and characterization of valsartan co-crystals to improve its aqueous solubility and dissolution behavior. Res J Pharm Technol. 2017; 10(1): 26–30. doi.org/10.5958/0974-360X.2017.00007.5
21.    Patil UK, Jain S, Yadav SK. Preparation and Evaluation of Sustained Release Matrix Tablet of Furosemide Using Natural Polymers, Research J. Pharm. Tech. 2008; 374–376. https://rjptonline.org/AbstractView.aspx?PID=2008-1-4-70
22.    Patel VD, Yegnoor AK. Development and evaluation of Celecoxib core in cup tablets for pulsatile drug delivery. Res. J. Pharm Technol. 2017; 10(3): 755–764. Available on: https://rjptonline.org/AbstractView.aspx?PID=2017-10-3-20
23.    Chemate SZ, Chowdary KPR. A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing hp-[beta]-cyclodextrin and surfactants. Int J Pharm Sci Res. 2012; 3(7): 2252. doi.org/ 10.13040/IJPSR.0975-8232.3(7).2252-56
24.    Jagtap VA, Talele AN, Bendale AR, Narkhede S, Jadhav A, Vidyasagar G. Solubility Enhancement of Pioglitazone by Using Poloxamer (188 and 407) with the Help of Kneading Method. Res. J. Pharm. Technol. 2010; 3(4): 1152–1157. https://rjptonline.org/AbstractView.aspx?PID=2010-3-4-146
25.    Priya AS, Sivakamavalli J, Vaseeharan B, Stalin T. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin. Int J Biol Macromol. 2013; 62: 472–480. doi.org/10.1016/j.ijbiomac.2013.09.006

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available